powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1003254186
Claudio Bravo Carrillo
M.D.
Advanced Heart Failure and Transplant Cardiology
San Francisco,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
47
By payment type
Food and Beverage
$2K
QUALITY · MIPS · 2024
Final MIPS score
85.6
Quality
68.1
Cost
74.0
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.45%
Group
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CCN 050454
Hospital
CCN 050457
Hospital
CCN 450647
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
129
Beneficiaries
—
Total drug cost
$46K
Distinct drugs
8
Brand share
52.7%
Top prescribed drugs
Empagliflozin
24 claims
Sacubitril/Valsartan
20 claims
Atorvastatin Calcium
17 claims
Pravastatin Sodium
15 claims
Alendronate Sodium
15 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
103
Unique beneficiaries
—
Total services
261
Distinct HCPCS
4
Medicare payment
$33K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 65 Advanced Heart Failure and Transplant Cardiology providers in CA — bottom quintile (cohort median 1,349).
